Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Pelion SA (PELIO)

Warsaw
Currency in PLN
Disclaimer
58.80
0.00(0.00%)
Closed
PELIO Scorecard
Fair Value
Day's Range
58.8058.98
52 wk Range
0.0058.98
Bid/Ask
58.81 / 58.94
Prev. Close
58.8
Open
58.98
Day's Range
58.8-58.98
52 wk Range
0-0
Volume
0
Average Vol. (3m)
248
1-Year Change
0%
Shares Outstanding
9,372,414
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about PELIO?
Vote to see community's results!
or

Pelion SA Company Profile

Pelion S.A. engages in the trade of pharmaceuticals, cosmetics, and parapharmaceuticals in Poland. It operates through Wholesale, Retail, and Hospital supplies and logistics services segments. The company is involved in the wholesale and retail sale of pharmaceuticals to pharmacies, outpatient clinics, medical stores, etc., as well as in-patient healthcare institutions, hospitals, and wholesalers; and retail sale of dermocosmetics, such as personal care cosmetics, make-up products, nail care products, hair and body care products, and fragrances. It operates approximately 900 outlets under the DOZ Apteki dbam o zdrowie brand name; 300 beauty stores under the Natura name; 330 own and franchise pharmacies under the Gintarine Vaistine and Norfos Vaistine brands; 140 BVG partner pharmacies; e-pharmacies, including doz.pl and vaistine; and beauty e-stores comprising drogerienatura.pl and dozdrogeria.pl, as well as publishes Farmakoekonomika szpitalna, a quarterly magazine distributed to hospitals and pharmacies. The company also offers logistics services related to the management, warehousing, and distribution of drugs for the pharmaceutical industry; and business process outsourcing services, such as outsourcing of accounting and reporting, HR and payroll, management accounting, tax, financing process support, and business advisory services, as well as consolidation of financial statements. In addition, it provides credit risk management, contract-based manufacturing, and medical services, as well as pharmaceutical insurance products based on private drug refund schemes; develops and commercializes anti-atherogenic drugs, dermocosmetics, food and dietary supplements, and galenic preparations; and designs and develops healthcare solutions. Pelion S.A. was formerly known as Polska Grupa Farmaceutyczna SA and changed its name to Pelion S.A. in November 2011. The company was founded in 1990 and is based in Lódz, Poland.

Employees
8973
Market
Poland
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.